Recent Articles from Business Wire

Parameter Technologies Announces Agreement to Be Acquired by Acuity Inc. as Part of Distech Controls™
Parameter Technologies (“Parameter”) today announced that it has entered into a definitive agreement to be acquired by Acuity Inc. (NYSE: AYI) (“Acuity”) for a purchase price of $675 million. Upon closing, Parameter will become part of Distech Controls within the Acuity Intelligent Spaces business segment.
By Parameter Technologies · Via Business Wire · October 26, 2026
HeartBeam’s Heart Attack Assessment Technology Accepted into FDA’s Total Product Life Cycle Advisory Program (TAP)
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced that the U.S. Food and Drug Administration (FDA) has accepted the HeartBeam System into its Total Product Life Cycle Advisory Program (TAP) Pilot, a voluntary FDA program to accelerate patient access to Breakthrough medical devices. The acceptance, which was awarded ahead of schedule, applies to HeartBeam’s 3D ECG technology, which received FDA Breakthrough Device Designation earlier this month, as a tool for assessing potential heart attacks outside of a medical setting.
By HeartBeam, Inc. · Via Business Wire · October 26, 2026
Digimarc Returns from RGCA with Strong Market Interest in Its Next-Generation Gift Card Security
Digimarc Corporation (NASDAQ: DMRC), a leading provider of digital identity and authentication technologies, today announced strong market momentum for its gift card security solution following a highly successful week at the 2026 Retail Gift Card Association (RGCA) industry event in Denver, CO.
By Digimarc Corporation · Via Business Wire · October 26, 2026
XTEND Reports Preliminary Third Quarter 2026 Results, Names Former Navy SEAL Captain Matt McGraw U.S. CEO, and Issues Letter to Shareholders
XTEND AI Robotics (NYSE: XTND) (“XTEND” or the “Company”), the software and execution layer for autonomous systems, today announced preliminary, unaudited revenue for the nine months ended September 30, 2026 and the appointment of Matt McGraw as Chief Executive Officer of XTEND U.S. Co-Founder and CEO Aviv Shapira also issued a letter to shareholders, available at xtend.me/letter-to-investors.
By XTEND AI Robotics, Inc. · Via Business Wire · October 26, 2026
Boston Omaha Corporation Completes Sale of its Surety Insurance Business Unit to CopperPoint Insurance Company
Boston Omaha Corporation (NYSE:BOC) (“Boston Omaha” or the “Company”) today announced that it has completed the sale of its surety insurance business, operated by General Indemnity Group, LLC (“GIG”), to CopperPoint Insurance Company (“CopperPoint”). The transaction is structured as an all-cash transaction under which CopperPoint acquired all of the outstanding equity interests of GIG.
By Boston Omaha Corporation · Via Business Wire · October 26, 2026
Empery Digital Resumes Share Repurchases and Provides Update on Capital Allocation Priorities and Midwest Data Center Investment
Empery Digital Inc. (NASDAQ: EMPD) (the “Company” or “Empery Digital”) today provided an update on its share repurchases, capital allocation priorities and Midwest AI data center investment.
By Empery Digital Inc. · Via Business Wire · October 26, 2026
Audi and Universal Display Celebrate 10 Years of OLED Technology in Audi Production Vehicles
Universal Display Corporation (UDC) (Nasdaq: OLED) and Audi celebrated ten years of OLED technology in Audi production vehicles, marking a decade of innovation that has transformed OLED lighting into one of the automotive industry’s most distinctive, energy-efficient and technologically advanced lighting platforms. The announcement follows Audi’s event in Ingolstadt, Germany recognizing a decade of OLED technology across its vehicle portfolio. Together with OLEDWorks, the companies are highlighting how OLED automotive lighting has evolved and its growing role in the future of automotive design, functionality and communication.
By Universal Display Corporation · Via Business Wire · October 26, 2026
Bank of Marin Bancorp Reports Third Quarter Financial Results Driven by Loan Growth, NIM Expansion and Higher Earnings
Bank of Marin Bancorp, "Bancorp" (Nasdaq: BMRC), parent company of Bank of Marin, "Bank," completed another quarter of improved financial performance, reflecting continued enhanced profitability and overall balance sheet strength. This performance was supported by progress across key financial and operating priorities:
By Bank of Marin Bancorp · Via Business Wire · October 26, 2026
Intrepid Selected for USDA Matching Grant Award to Support Carlsbad Sulfate of Potash Project
Intrepid Potash, Inc. (“Intrepid” or “the Company”) (NYSE:IPI), a leading diversified mineral company serving the agriculture and animal feed markets, and the only U.S. producer of muriate of potash, today announced that the U.S. Department of Agriculture (“USDA”) selected Intrepid’s sulfate of potash (SOP) project for approximately $139 million in proposed matching funding to support the construction of a SOP manufacturing facility near Carlsbad, New Mexico, through its Fertilizer Investment & Expansion for Long-Term Domestic Supply (“FIELDS”) program. If constructed, the SOP plant would introduce a new product to Intrepid’s portfolio, further diversifying the Company’s product offerings and expanding its presence in specialty fertilizer markets by complementing its Trio® and potash fertilizer products.
By Intrepid Potash, Inc · Via Business Wire · October 26, 2026
MasterBrand Announces CFO Transition
MasterBrand, Inc. (NYSE: MBC, the “Company,” or “MasterBrand”), the largest residential cabinet manufacturer in North America, today announced the appointment of Mark Young, Vice President and Chief Accounting Officer, as Vice President and Interim Chief Financial Officer, effective immediately. He succeeds Andrea Simon, who has agreed to remain with the Company in an advisory capacity through March 31, 2027, to facilitate a seamless transition. The Company has initiated a comprehensive search process, with the assistance of a leading executive search firm, to identify a permanent CFO from internal and external candidates. Ms. Simon’s departure is not related to any issues with respect to the integrity of the Company’s financial statements or accounting policies and practices.
By MasterBrand, Inc. · Via Business Wire · October 26, 2026
Tempus Receives IVDR Certification for xR RNA Sequencing for Solid Tumor Profiling
Tempus AI, Inc. (NASDAQ: TEM) today announced that its xR assay has received certification under the European Union’s In Vitro Diagnostic Regulation (IVDR) as a Class C in vitro diagnostic device. The certification covers Tempus’ quality management system for "next-generation sequencing devices for cancer genomic profiling to support clinical management."
By Tempus AI, Inc. · Via Business Wire · October 26, 2026
ACMC Partners with AI Resource Intelligence Company Scepter to Evaluate Critical Minerals Projects
Africa Critical Minerals Corporation (ACMC) and Scepter, Inc. signed an MOU to use Scepter’s AI to evaluate African critical minerals projects for ACMC’s development platform.
Delcath Systems to Host Third Quarter 2026 Earnings Call
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on November 9, 2026, at 8:30 AM Eastern Time to discuss results for its third quarter ended September 30, 2026.
By Delcath Systems, Inc. · Via Business Wire · October 26, 2026
Herc Holdings Inc. Announces CEO Succession Plan
Herc Holdings Inc. (NYSE: HRI), one of North America’s leading equipment rental suppliers operating through Herc Rentals Inc. (“Herc Holdings,” “Herc Rentals” or the “Company”), today announced that, as part of the Company’s planned leadership succession, Aaron Birnbaum, currently president, will succeed Larry Silber as chief executive officer, effective Jan. 1, 2027. Birnbaum will also continue in his role as president and will join the Company’s Board of Directors (the “Board”) at that time. Silber, who has served as CEO since 2015 and a member of the Board since 2016, will transition to executive chairman of the Board.
By Herc Holdings Inc. · Via Business Wire · October 26, 2026
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Schrödinger, Inc. (Nasdaq: SDGR) today reported that on October 21, 2026, the company granted restricted stock units (RSUs) with respect to 5,716 shares of the company’s common stock to five newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the company’s board of directors, and were made as a material inducement to such employees’ acceptance of employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4) as a component of his or her employment compensation.
By Schrödinger · Via Business Wire · October 26, 2026
Paradium.AI to Host Third Quarter 2026 Financial Results Conference Call on Monday, November 9, 2026
Paradium.AI, Inc. (NYSE American: PAAI) (the “Company” or “Paradium.AI” or “Paradium”), a technology leader in IP, data and commerce that builds and operates a unified, AI-powered ecosystem designed to empower creators, media entrepreneurs, publishers and brands—today announced that it will release its financial results for the third quarter ended September 30, 2026, on Monday, November 9, 2026, following the close of the market.
By Paradium.AI, Inc. · Via Business Wire · October 26, 2026
ORAFOL Fresnel Optics Cuts Inspection Times in Half with Zebra Technologies’ AI Machine Vision Solution
Zebra Technologies Corporation (NASDAQ: ZBRA), a global leader in digitising and automating workflows to deliver intelligent operations, today announced ORAFOL Fresnel Optics GmbH has intelligently automated the quality inspection of over 1.5 million optical lenses, using bespoke inspection systems powered by Zebra’s AI machine vision solution.
By Zebra Technologies Corporation · Via Business Wire · October 26, 2026
Dubai Culture Opens Registration for ISEA2026 Dubai
Dubai Culture and Arts Authority (Dubai Culture) has opened registration for the 31st International Symposium on Electronic/Emerging Art (ISEA2026 Dubai), taking place from 6 to 15 November 2026 under the theme ‘ELYAH: Constellating Place, Data and Identity’. The symposium will be the largest edition to date, bringing together artists, researchers, and innovators from around the world to explore the intersection of art, science, and technology and exchange perspectives on the future of contemporary creative practice.
By Dubai Culture · Via Business Wire · October 26, 2026
Medifast Announces Third Quarter 2026 Financial Results
Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy™, today reported results for the third quarter ended September 30, 2026.
By Medifast · Via Business Wire · October 26, 2026
Ameresco Completes $5.9M Advanced Metering Infrastructure Project for the City of Mustang, Oklahoma
Ameresco, Inc., (NYSE: AMRC), a leading energy infrastructure company delivering integrated solutions to create reliable power and modernize infrastructure, today announced the completion of an Advanced Metering Infrastructure (AMI) water meter project for the City of Mustang, Oklahoma. The $5.9M project replaced more than 8,000 water meters, modernizing the City’s metering system and supporting the long-term success of its water utility operations.
By Ameresco, Inc. · Via Business Wire · October 26, 2026
Sierra Bancorp Reports Record Quarterly Income
Sierra Bancorp (Nasdaq: BSRR), parent of Bank of the Sierra, today announced its unaudited financial results for the three- and nine-month periods ended September 30, 2026. Sierra Bancorp reported consolidated net income of $15.3 million, or $1.18 per diluted share, for the third quarter of 2026, compared to $9.7 million, or $0.72 per diluted share, in the third quarter of 2025. Return on average assets was 1.66% and return on average equity was 16.49% for the third quarter of 2026, compared to 1.04% and 10.81%, respectively, for the same period in 2025.
By Sierra Bancorp · Via Business Wire · October 26, 2026
Object First Earns Dual Honors for Innovation in Data Security and Ransomware Protection
Object First, the ransomware-proof on-premises backup storage company, today announced that it has received two prestigious cybersecurity awards celebrating its innovation and commitment to protecting organizations against ransomware attacks.
By Object First · Via Business Wire · October 26, 2026
Town Lane Raises $1.9 Billion for Second Real Estate Investment Fund
Town Lane (“Town Lane” or the “Firm”), a boutique real estate investment firm, today announced the final close of Town Lane Real Estate Opportunities Fund II (“Fund II”) at its hard cap with $1.9 billion in investor commitments, up from the $1.25 billion raised for its inaugural fund in 2024. Fund II surpassed its $1.5 billion target over the course of the summer and is backed by a diverse group of experienced institutional investors, including university endowments, charitable foundations, family offices and pension funds, with strong support from returning Fund I investors.
By Town Lane · Via Business Wire · October 26, 2026
Shionogi to Present New Real-World Data Advancing the Understanding of ALS at the 2026 Annual NEALS Meeting
Shionogi Inc., a New Jersey-based subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.), will present three posters at the 2026 Annual Network of Excellence for Amyotrophic Lateral Sclerosis (NEALS) Meeting, taking place October 27-30 in Clearwater, Florida. Shionogi remains committed to advancing ALS research and expanding the understanding of RADICAVA ORS® (edaravone), including through real-world evidence and innovative approaches to disease monitoring.
By Shionogi Inc. · Via Business Wire · October 26, 2026
Dynex Capital, Inc. Named One of TIME’s America’s Growth Leaders for 2027
Dynex Capital, Inc. (NYSE: DX, “Dynex” or the “Company”) is proud to announce its inclusion in the America’s Growth Leaders 2027 list, a distinguished ranking honoring companies demonstrating exceptional growth performance, financial stability, and stock performance. This recognition is presented by TIME and Statista, global leaders in data analysis and industry benchmarking, and it can now be viewed on time.com.
By Dynex Capital, Inc. · Via Business Wire · October 26, 2026
Vyome Co-Founder Dr. Shiladitya Sengupta Promoted to Professor at Harvard Medical School
Vyome Holdings, Inc. (Nasdaq: HIND) ("Vyome"), a clinical-stage biopharmaceutical company focused on immuno-inflammatory and rare disease conditions, today congratulated its Scientific Co-Founder and Director, Dr. Shiladitya Sengupta, PhD, on his promotion to Professor of Medicine at Harvard Medical School. The academic recognition marks an important milestone in Dr. Sengupta’s distinguished scientific career, spanning biomedical research, nanomedicine, bioengineering, drug delivery, and the translation of scientific discoveries into potential therapeutic applications.
By Vyome Holdings, Inc. · Via Business Wire · October 26, 2026
Corcept Reports Positive Results from Phase 2 BELLA Trial of Lifyorli® Combined with Nab-Paclitaxel and Bevacizumab in Patients with Platinum-Resistant Ovarian Cancer
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced positive results from Part A of the company’s Phase 2 BELLA trial, which evaluated Lifyorli in combination with nab-paclitaxel and bevacizumab in 95 patients with platinum-resistant ovarian cancer.
By Corcept Therapeutics Incorporated · Via Business Wire · October 26, 2026
o9 Solutions Named a Leader in Analyst Evaluation of Supply Chain Platforms, Q3 2026
o9 Solutions, a leading software company that is powering enterprise planning and decisioning models across 30-plus industry verticals with its groundbreaking, AI-powered Digital Brain platform, today announced that it has been named a Leader in The Forrester Wave™: Supply Chain Platforms, Q3 2026. o9 received the highest possible score in nine evaluation criteria, including synchronization of master data, supply network optimization, architecture, exploitation of language models, and Vision.
By o9 Solutions · Via Business Wire · October 26, 2026
GigCapital9 Announces Letter of Intent for Proposed Business Combination with a Leading Clean Energy Technology Company
GigCapital9 Corp. (Nasdaq: GIX) (“GigCapital9” or the “Company”), a publicly traded Private-to-Public Equity (PPE)™ Mentor Investor™, today announced that it has entered into a non-binding Letter of Intent (“LOI”) with a leading clean energy technology company focusing on post-combustion carbon capture solutions.
By GigCapital9 Corp. · Via Business Wire · October 26, 2026
DT Research Unveils LT365PA Rugged Laptop Bringing NVIDIA Graphics and AI Processing to Mission-Critical Field Teams
DT Research, the leading U.S. designer and manufacturer of AI-capable, rugged computing solutions purpose-engineered for enterprise-scale customization, today announced the LT365PA Rugged Laptop, a high-performance mobile workstation that brings NVIDIA graphics, AI processing and advanced image analysis directly to law enforcement, forensic and military field operations, including mobile command environments that require local processing of multiple sensor inputs, video feeds, drone imagery and AI analytics.
By DT Research · Via Business Wire · October 26, 2026
CEL-SCI Presents New Phase 3 Multikine® Data at World Congress: Pre-Surgical Biomarkers Identify Head & Neck Cancer Patients Achieving 73% 5-Year Survival
CEL-SCI Corporation (NYSE American: CVM) today announced positive new pre-surgical tumor response and safety analyses from its completed Phase 3 study of Multikine® (Leukocyte Interleukin, Injection)*. The findings were presented by the Company’s Chief Scientific Officer and developer of Multikine, Dr. Eyal Talor, during a keynote address at the 6th World Congress on Otology, Rhinology and Laryngology in Rome, Italy.
By CEL-SCI Corporation · Via Business Wire · October 26, 2026
Archer To Report Third Quarter 2026 Operating Update and Financial Results on November 9th, 2026
Archer Aviation Inc. (NYSE: ACHR) will report its third quarter 2026 operating update and financial results after market close on Monday, November 9th, 2026. Archer will host a live webcast to discuss its results at 2:00 p.m. Pacific Time.
By Archer Aviation · Via Business Wire · October 26, 2026
Cyera Earns FedRAMP® High (Class D) Certified Status, Clearing the Way for Federal Agencies to Safely Adopt Agentic AI
While AI is reshaping how organizations operate, trust in the data powering it becomes the most critical layer of security. Nowhere is that more true than in government, where agencies are stewards of the nation's most sensitive data, safeguarding national security, critical infrastructure, and the personal information of every citizen. And as those agencies scale AI, the platforms behind that data must meet the government's highest standard for security and prove they can be trusted, ensuring agencies the ability to move at the same pace as AI adoption itself.
By Cyera · Via Business Wire · October 26, 2026
Stem Announces Review of Strategic Alternatives to Maximize Shareholder Value
Stem, Inc. (NYSE: STEM) (the “Company”), a global leader in AI-enabled clean energy software and services, today announced that its Board of Directors (the “Board”) has initiated a formal review of strategic alternatives to maximize shareholder value. The Company has engaged Guggenheim Securities, LLC as financial advisor and Gibson Dunn & Crutcher LLP, and Davis Polk & Wardwell LLP, as legal advisors to assist with the review. 
By Stem, Inc. · Via Business Wire · October 26, 2026
Estrella Immunopharma Appoints Cynthia Pussinen as Chief Executive Officer and Chairperson of the Board of Directors
Estrella Immunopharma, Inc. (NASDAQ: ESLA) (“Estrella” or the “Company”), a clinical-stage biopharmaceutical company developing next-generation ARTEMIS® T-cell therapies for the treatment of cancer and autoimmune diseases, today announced the appointment of Cynthia Pussinen as Chief Executive Officer and Chairperson of its Board of Directors, effective October 25, 2026. Ms. Pussinen succeeds Cheng Liu, Ph.D., as Chief Executive Officer. Dr. Liu has been appointed Chief Scientific Officer and will continue to serve as the Company's President and as a member of the Board of Directors.
By Estrella Immunopharma, Inc. · Via Business Wire · October 26, 2026
Solid Power Announces Significant Advancement in Commercial Pathway, Commissioning MOBIUS™ Continuous Electrolyte Manufacturing Line
Solid Power, Inc. (Nasdaq: SLDP), a leading U.S.-based developer of solid-state battery technology, today announced that it has begun commissioning MOBIUS™, its continuous manufacturing pilot line for sulfide-based solid electrolyte. Previously referred to as the SP2.5 Continuous Manufacturing Pilot Line, MOBIUS™ has reached substantial completion of construction at Solid Power’s SP2 facility in Thornton, Colorado, and materials are now being introduced into the line. MOBIUS™ supports Solid Power’s objective to manufacture and sell electrolyte to Tier 1 battery manufacturers and automotive original equipment manufacturers (OEMs).
By Solid Power, Inc. · Via Business Wire · October 26, 2026
Mubadala Capital Announces Strategic Investment from Apollo
Mubadala Capital, the alternative asset management arm of Mubadala Investment Company, today announced a strategic investment from Apollo (NYSE: APO) to support its next phase of growth. Building on their existing relationship, Apollo will take a minority equity stake in Mubadala Capital and commit capital across its various investment strategies, working alongside Mubadala Capital as it continues scaling a world-class alternative asset manager.
By Mubadala Capital and Apollo · Via Business Wire · October 26, 2026
Iambic Presents Updated IAM1363 Clinical Data at ESMO 2026, Showing Durable Responses with a Favorable Tolerability Profile in Heavily Pretreated Participants with HER2-Driven Cancers
Iambic Therapeutics, Inc. (Iambic) (Nasdaq: IAM), a clinical-stage life sciences and technology company developing novel medicines using its AI-driven platform, today announced updated clinical data for IAM1363, a selective and brain-penetrant HER2 tyrosine kinase inhibitor (TKI), from its ongoing Phase 1/1b clinical trial. The data, which showed durable anti-tumor activity, intracranial responses and a favorable tolerability profile in heavily pretreated participants with HER2-altered advanced cancers, were presented in a poster at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid on October 23, 2026.
By Iambic Therapeutics, Inc. · Via Business Wire · October 26, 2026
Mirum Pharmaceuticals Announces Positive Results from Cohort 2 of the Pivotal PROGRESS Study of ATEBRIOZ™ (zilurgisertib) in Pediatric Patients Aged 6 to <12 Years with Fibrodysplasia Ossificans Progressiva
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a leading rare disease company, today announced positive results from Cohort 2 of the pivotal PROGRESS study of ATEBRIOZ™ (zilurgisertib), an oral activin receptor-like kinase 2 (ALK2) inhibitor, in pediatric patients aged 6 to <12 years with fibrodysplasia ossificans progressiva (FOP). At Week 24, zilurgisertib reduced total heterotopic ossification (HO) lesion volume and improved clinician-assessed joint mobility. No zilurgisertib-treated patients developed new HO lesions.
By Mirum Pharmaceuticals, Inc. · Via Business Wire · October 26, 2026
Sumitomo Pharma America Announces Enzomenib (DSP-5336) Receives FDA Breakthrough Therapy Designation for Treatment of R/R KMT2A-Rearranged Acute Leukemia
Sumitomo Pharma America, Inc. (SMPA) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to enzomenib (DSP-5336) for the treatment of patients with relapsed/refractory acute leukemia with KMT2A rearrangement (R/R KMT2Ar). Enzomenib is an investigational, oral, small molecule inhibitor of the menin and lysine (K)-specific methyltransferase 2A (KMT2A) protein interaction, a key interaction in acute leukemia and implicated in tumor cell proliferation and growth.
By Sumitomo Pharma America, Inc. · Via Business Wire · October 26, 2026
Twist Bioscience to Report Fiscal 2026 Fourth Quarter and Full Year Financial Results on Thursday, November 12, 2026
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value healthcare company, today announced that it will issue its financial results for the fiscal 2026 fourth quarter and full year ended September 30, 2026, before the opening of the market on November 12, 2026. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial results and provide an update on the company’s business. The press release with the financial results will be accessible from the company’s website prior to the conference call through the Investor Relations section under the “Company” tab at www.twistbioscience.com.
By Twist Bioscience Corporation · Via Business Wire · October 26, 2026
Genesys Earns 2026 Great Place to Work Certification Across 23 Countries
Genesys®, a global leader in agentic orchestration for customer experience (CX), today announced that it has been Certified™ as a Great Place to Work® across 23 countries. The recognition is rooted in the experiences of Genesys employees, with 92% of those surveyed saying the company is a great place to work. The results reflect the company’s continued commitment to fostering a workplace where people feel supported, empowered to grow and connected to the impact of their work.
By Genesys · Via Business Wire · October 26, 2026
The LYCRA Company to Showcase Performance Innovations Across Wovens and Knits at Functional Fabric Fair in Portland
The LYCRA Company, a global leader in fiber and technology solutions for the apparel and personal care industries, will showcase high-performance innovations for the next generation of outdoor, lifestyle, activewear and workwear textiles at Functional Fabric Fair, taking place October 27–28, 2026, at the Oregon Convention Center in Portland.
By The LYCRA Company · Via Business Wire · October 26, 2026
Agendia Unveils Clinical Validation of AI-Driven Digital Pathology Approach
Agendia, Inc., a leader in precision oncology for breast cancer, recently presented research introducing its investigational artificial intelligence (AI)-driven digital pathology approach for the MammaPrint® 70-gene recurrence signature at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid. The podium presentation, delivered by co-founder and Chief Research Officer, Laura van ’t Veer, Ph.D., detailed the development and clinical validation of a deep learning pipeline that can infer MammaPrint (MP) risk categories directly from hematoxylin and eosin (H&E)-stained, whole-slide images (WSIs). The company also presented two additional posters highlighting data from the prospective, real-world FLEX Study (NCT03053193).
By Agendia, Inc. · Via Business Wire · October 26, 2026
Walmart Expands Better Care Services, Powered by General Medicine’s Healthcare Store
Following the launch of Better Care Services earlier this year, Walmart today announced a major expansion of its Better Care Services platform with a healthcare-store experience powered by General Medicine, further expanding its marketplace of third-party providers. Combining Walmart’s reach and established consumer offerings with General Medicine’s purpose-built care catalog, the expanded experience brings customers more care options, a single catalog that makes it easier to compare services across third-party providers, and upfront information about potential costs with and without insurance.
By Walmart Inc. · Via Business Wire · October 26, 2026
Wellpoint Maryland Earns 4-Star NCQA Rating and Recognition for Health Outcomes and Community-Focused Care
Wellpoint Maryland, Inc., a Medicaid health plan serving Maryland residents in every county across the state, earned 4 out of 5 stars in the National Committee for Quality Assurance's (NCQA) 2026 Medicaid Health Plan Ratings, up from 3.5 stars the previous year. The health plan also holds NCQA Health Outcomes Accreditation and Community-Focused Care Accreditation, recognizing its work to understand and address the health and social needs of the populations it serves.
By Wellpoint · Via Business Wire · October 26, 2026
Hadron Energy Strengthens Halo Reactor Engineering Team with Three Senior Component Design and Analysis Leaders
Hadron Energy, Inc. (Nasdaq: HDRN) ("Hadron" or the "Company"), a developer of light-water micro-modular nuclear reactor technology, today announced the addition of three senior engineering leaders to its team. Together they bring more than 40 years of engineering experience, including 25 years in the nuclear industry, across reactor vessel and internals design, mechanical systems design, and the structural integrity of pressure boundary components.
By Hadron Energy, Inc. · Via Business Wire · October 26, 2026
L Catterton Announces Strategic Investment in Glance
L Catterton, the largest global consumer-focused investment firm, today announced a strategic investment in Glance, an AI-powered personal shopping platform backed by global technology company InMobi. The investment reflects L Catterton’s conviction in Glance’s potential to help shape the future of shopping as artificial intelligence changes how consumers find and purchase products.
By InMobi · Via Business Wire · October 26, 2026
Acelot to Present on TDP-43 Targeting in ALS at 2026 NEALS Meeting
Acelot, a biotechnology company developing small molecule therapies for challenging targets in diseases with high unmet need, today announced that Acelot CMO & CDO Mark Forman, MD, PhD, will present preclinical data from the company’s TDP-43 program at the upcoming 2026 Annual Network of Excellence for ALS (NEALS) meeting, taking place October 27-30 in Clearwater, FL and virtually. Additionally, Acelot CEO Katie Planey, PhD, MBA, will participate in an industry roundtable discussing the advancement of TDP-43-relevant therapeutic targets.
By Acelot · Via Business Wire · October 26, 2026
Westwin Elements Appoints David Kronenfeld as Chief Legal Officer
Westwin Elements, America’s only Class 1 nickel refinery, today announced the appointment of David Kronenfeld as Chief Legal Officer. Kronenfeld joins Westwin from USA Rare Earth, Inc., where he most recently was General Counsel. He brings over 15 years of corporate legal experience to the role, including expertise in critical minerals, corporate transactions, and securities law.
By Westwin Elements · Via Business Wire · October 26, 2026
VantageScore CreditGauge™ September 2026: Overall Balances Hold Steady as Consumer Credit Remains Stable
In September 2026, consumer credit remained resilient despite early-stage payment pressure, according to the latest edition of CreditGauge™ from VantageScore. Balances were stable, and credit card utilization remained below 2026 levels. The average VantageScore 4.0 credit score remained at 701, continuing a trend of steady consumer credit scores over the last year.
By VantageScore · Via Business Wire · October 26, 2026
Certinia Named a Visionary in the 2026 Gartner® Magic Quadrant™ for Customer Success Management Platforms
Certinia today announced it has been recognized as a Visionary in the 2026 Gartner® Magic Quadrant™ for Customer Success Management Platforms.
By Certinia · Via Business Wire · October 26, 2026
Coincheck Group N.V. to Announce Second Quarter 2027 Financial Results on November 9, 2026
Coincheck Group N.V. (NASDAQ: CNCK), a Dutch limited liability company that provides digital asset trade execution, custody, staking and asset management services, today announced that it plans to release its financial results for the quarter ended September 30, 2026, on Monday, November 9, 2026. The company will host a conference call to discuss the quarter at 5:00 pm ET that same day. Hosting the call will be Pascal St-Jean, Chief Executive Officer, and Jason Sandberg, Chief Financial Officer.
By Coincheck Group N.V. · Via Business Wire · October 26, 2026
Hamilton Reserve Bank Welcomes Robert Stern, Senior U.S. Insurance Executive to International Advisory Board
Hamilton Reserve Bank (HRB), the largest global bank headquartered in the Caribbean region with worldwide offices and US $25+ billion in custodial assets and deposits, serving clients from 150 countries, announces that Mr. Robert Stern, the former National Senior Medical Director of Anthem Blue Cross has joined Hamilton Reserve Bank’s esteemed International Advisory Board to support strategic development.
By Hamilton Reserve Bank · Via Business Wire · October 26, 2026
C.H. Robinson Debuts Lean AI for Ocean Shipping, Air Freight and Customs
As the global leader in Lean AI, C.H. Robinson has launched new AI agents that perform work in ocean shipping, air freight and customs brokerage. They represent an expansion of the company’s Lean AI capabilities into freight forwarding, for the benefit of more customers, and into work so complex that a single shipping task can require over a dozen AI agents working in tandem.
By C.H. Robinson · Via Business Wire · October 26, 2026
Fundway and Monex Partner to Bring FX and Currency Infrastructure to Fund Managers
Fundway (fundwayplatform.com), the free platform connecting fund managers with verified service providers, today announced a partnership with Monex, a leading specialist in private markets FX and currency infrastructure. Fund managers, whether preparing to launch or already running a fund, can now request an offer from Monex on Fundway.
By Fundway · Via Business Wire · October 26, 2026
Second Front Achieves U.S. Department of Veterans Affairs Authorization to Operate
Second Front (2F), a public-benefit software company powering software for the free world, today announced that the U.S. Department of Veterans Affairs (VA) has issued an Authorization to Operate (ATO) for 2F Game Warden, providing vendors a direct pathway to ship in-demand capabilities across the VA.
By Second Front Systems · Via Business Wire · October 26, 2026
Shark Beauty Launches Limited-Edition CryoGlow LED Mask Color, Co-Designed with Kevin Hart
SharkNinja, Inc. (NYSE: SN), a global product design and technology company, today unveiled a limited-edition color of the Shark CryoGlow LED Face Mask, in collaboration with SharkNinja global brand ambassador Kevin Hart. The new gunmetal and red finish pairs Shark Beauty's skincare technology with Hart's humor and style, and shows how men's self-care can be approachable and easy to fit into everyday life.
By SharkNinja · Via Business Wire · October 26, 2026
AtriCure to Participate at Upcoming Investor Conferences
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in two upcoming investor conferences.
By AtriCure, Inc. · Via Business Wire · October 26, 2026
KE Andrews Announces Next Phase of the Organization
KE Andrews is excited to announce the next phase of the organization as the firm continues to advance its service to an expanding client base. As KE Andrews looks toward the future, the firm remains committed to its role as a trusted advisor to clients throughout the entire life cycle of property ownership.
By KE Andrews · Via Business Wire · October 26, 2026
TCIM Provides Update on Voya’s Effort to Prevent the Voices of Shareholders from Being Heard
TOMS Capital Investment Management (“TCIM”), which manages funds that together have an investment representing an approximately 4.65% economic interest in Voya Financial, Inc. (NYSE: VOYA) (“Voya” or the “Company”), has filed definitive proxy materials to provide shareholders the opportunity to consider and vote on a non-binding resolution. This non-binding resolution allows shareholders to convey unequivocally that they “no longer continue to have confidence in the board of directors (the “Board”) and management of Voya Financial, Inc.”
TVS Motor Company Returns to EICMA With New Models for Europe
TVS Motor Company (TVSM), a global leader in two- and three-wheeler manufacturing, returns to EICMA in Milan this November, one year after its debut at the world’s largest two-wheeler exhibition. The company will present new models for Europe at a press conference on Tuesday, 3 November at 10:00 CET. The TVS stand is in Hall 18, Stand I64.
By TVS Motor Company · Via Business Wire · October 26, 2026
Open-Source AI Models Are Catching up to Closed Ones on Accounting Work, DualEntry Benchmark Finds
Moonshot AI's Kimi K3.1 Pro got 86.1% of tasks right on the DualEntry Accounting AI Benchmark, placing fourth and ahead of every model from Anthropic, OpenAI and Meta. With Zhipu AI's GLM-5.3 Flash tied for second at 88.1%, two of the top four models are now open.
By DualEntry · Via Business Wire · October 26, 2026
AST SpaceMobile Advances Brazil Expansion with Anatel’s Approval for S-band Spectrum and Secondary Use of the 700 MHz Band, Agreements with Four Regional Operators and Planned Ground Infrastructure
AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, designed for both commercial and government applications, today announced significant progress toward bringing space-based cellular broadband to Brazil, Latin America’s largest economy.
By AST SpaceMobile, Inc. · Via Business Wire · October 26, 2026
Brixton Biosciences Strengthens Executive Leadership Team to Support the Next Phase of Company Growth
Brixton Biosciences (Brixton), a clinical-stage life sciences company focused on developing a nerve-selective biomaterial designed to provide targeted and durable relief from pain, today announced the appointments of David Acheson as Chief Commercial Officer and Brian Newkirk as Chief Business Officer. The appointments strengthen Brixton's executive leadership team as the Company prepares for potential commercialization of its lead product, Reneurx™ Nerve-Selective Therapy for pain associated with knee osteoarthritis, with additional clinical and research initiatives focused on lateral hip pain, thumb joint pain and migraine.
By Brixton Biosciences · Via Business Wire · October 26, 2026
Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders
Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced the voting results from its annual general and special meeting of shareholders convened on September 25, 2026, and adjourned to and reconvened on October 23, 2026 (the “Meeting”).
By Canopy Growth Corporation · Via Business Wire · October 26, 2026
FTK Investors Have Opportunity to Lead Flotek Industries, Inc. Securities Fraud Lawsuit with SBS Law
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Flotek Industries, Inc. (“Flotek” or “the Company”) (NYSE: FTK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall, Brown & Schwartz LLP · Via Business Wire · October 26, 2026
Turning Point Brands to Host Q3 2026 Conference Call
Turning Point Brands, Inc. (NYSE: TPB) announced the date and time for its conference call to review third quarter 2026 results. The conference call will be on Monday, November 9th at 9:00 a.m. Eastern Time.
By Turning Point Brands, Inc. · Via Business Wire · October 26, 2026
City Holding Company Announces Record Quarterly Results
City Holding Company (“Company” or “City”) (NASDAQ:CHCO), a $6.8 billion bank holding company headquartered in Charleston, West Virginia, today announced net income of $34.6 million and record quarterly diluted earnings of $2.43 per share for the quarter ended September 30, 2026. For the quarter ended September 30, 2026, the Company achieved a return on assets of 2.03% and a return on tangible equity of 20.9%.
By City Holding Company · Via Business Wire · October 26, 2026
Light Chain Bioscience – Novimmune SA: Long-term Follow-up of NI-1801 in Platinum Resistant Ovarian Cancer Shows Durable Survival Benefit at 24 Months
Light Chain Bioscience, a clinical-stage biotechnology company advancing the next generation of bispecific antibodies to treat cancer, today presented updated long-term results from a Phase 1/1b study of NI-1801 as a monotherapy and in combination with pembrolizumab in heavily pretreated Platinum Resistant Ovarian Cancer (PROC) patients that have no approved standard of care treatment. The data were reported in a Poster presentation at European Society of Medical Oncology (ESMO) Congress in Madrid.
By Light Chain Bioscience · Via Business Wire · October 26, 2026
Silversmith Capital Partners Welcomes Jean Gulliver as Head of Investor Relations
Silversmith Capital Partners, a growth equity firm focused on supporting the best entrepreneurs in technology and healthcare, today announced the appointment of Jean Gulliver as Head of Investor Relations. In this role, Jean will lead the firm’s institutional investor relationships and capital formation efforts.
By Silversmith Capital Partners · Via Business Wire · October 26, 2026
Metropolitan Commercial Bank Earns Great Place To Work® Certification™ for Second Consecutive Year
Metropolitan Commercial Bank (“MCB” or the “Bank”), a full-service commercial bank headquartered in New York City, is proud to announce that it has been Certified™ by Great Place To Work® for the second year in a row, reaffirming the Bank's commitment to fostering an exceptional workplace culture where employees feel valued, supported, and empowered to succeed.
By Metropolitan Commercial Bank · Via Business Wire · October 26, 2026
Aulos Bioscience’s Imneskibart With Avelumab Delivers Exceptional Progression-Free Survival in Checkpoint Inhibitor-Refractory Adenocarcinoma Non-Small Cell Lung Cancer
Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through development of its lead immune-activating antibody therapeutic imneskibart (AU-007), today presented positive Phase 2 data for imneskibart with avelumab in checkpoint inhibitor (CPI)-refractory adenocarcinoma non-small cell lung cancer (NSCLC). The data were shared in a poster session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain.
By Aulos Bioscience · Via Business Wire · October 26, 2026
FedEx Names Jamere Jackson as Executive Vice President and Chief Financial Officer
FedEx Corp. (NYSE: FDX) today announced the appointment of Jamere Jackson as chief financial officer, effective Nov. 30. He succeeds Claude Russ, who has served as interim CFO since June 1.
By FedEx Corp. · Via Business Wire · October 26, 2026
Walmart Unwraps Three Major Holiday Shopping Events, Bringing Big Savings on Gifts and Seasonal Favorites
The holidays should be about making memories, not making compromises. But with budgets stretched, busy schedules and growing shopping lists, customers are looking for ways to make the season special without added stress. Walmart is making it easier with three major holiday shopping events from November 12 through December 2, bringing savings on gifts, seasonal favorites and everyday essentials – plus a new holiday marketing campaign.
By Walmart Inc. · Via Business Wire · October 26, 2026
Articles from Business Wire | MarketMinute